These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6087414)

  • 1. Experimental studies of latency in vitro by herpes simplex viruses.
    Rapp F
    Prog Med Virol; 1984; 30():29-43. PubMed ID: 6087414
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the molecular biology of herpes simplex virus.
    Becker Y
    Isr J Med Sci; 1972; 8(8):1216-24. PubMed ID: 4346002
    [No Abstract]   [Full Text] [Related]  

  • 3. Herpes simplex virus latency in SV40 hamster tumour cells.
    Boldogh I; Géder L; Váczi L
    Acta Microbiol Acad Sci Hung; 1973 Feb; 20(2):127-34. PubMed ID: 4359669
    [No Abstract]   [Full Text] [Related]  

  • 4. Self-limiting infection with herpes simplex virus in cell culture.
    Blackmore RV; Morgan HR
    Acta Virol; 1967 Jan; 11(1):1-12. PubMed ID: 4382129
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of E-5-(2-bromovinyl)-2'-deoxyuridine and other selective anti-herpes compounds on the induction of retrovirus particles in mouse BALB/3T3 cells.
    De Clercq E; Heremans H; Descamps J; Verhelst G; De Ley M; Billiau A
    Mol Pharmacol; 1981 Jan; 19(1):122-9. PubMed ID: 7207456
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiviral activity of Australian tea tree oil and eucalyptus oil against herpes simplex virus in cell culture.
    Schnitzler P; Schön K; Reichling J
    Pharmazie; 2001 Apr; 56(4):343-7. PubMed ID: 11338678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex virus latency: molecular aspects.
    Ho DY
    Prog Med Virol; 1992; 39():76-115. PubMed ID: 1317601
    [No Abstract]   [Full Text] [Related]  

  • 8. Herpes simplex virus latency in cultured human cells following treatment with cytosine arabinoside.
    O'Neill FJ; Goldberg RJ; Rapp F
    J Gen Virol; 1972 Feb; 14(2):189-97. PubMed ID: 4334781
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential inhibition of herpes simplex viruses, type 1 (HSV-1) an type 2 (HSV-2), by (E)-5-(2-X-vinyl)-2'-deoxyuridines.
    de Clercq E; Verhelst G; Descamps J; Bergstrom DE
    Acta Microbiol Acad Sci Hung; 1981; 28(3):307-12. PubMed ID: 6272553
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral activity of cyclosaligenyl prodrugs of the nucleoside analogue bromovinyldeoxyuridine against herpes viruses.
    Meerbach A; Meier C; Sauerbrei A; Meckel HM; Wutzler P
    Int J Antimicrob Agents; 2006 May; 27(5):423-30. PubMed ID: 16621459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental study of the cytopathogenic effects of Herpes simplex virus].
    Brouet JL; LOPEZ EV
    Rev Sanid Hig Publica (Madr); 1974 Jun; 48(6):553-9. PubMed ID: 4374739
    [No Abstract]   [Full Text] [Related]  

  • 13. Herpes simplex infection of HEp-2 and L-929 cells. 2. The kinetics of virus multiplication and cell lysis, and the measurement of interferon production.
    Underwood PA
    Microbios; 1972; 5(19):167-76. PubMed ID: 4361838
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiviral activity of Rhus aromatica (fragrant sumac) extract against two types of herpes simplex viruses in cell culture.
    Reichling J; Neuner A; Sharaf M; Harkenthal M; Schnitzler P
    Pharmazie; 2009 Aug; 64(8):538-41. PubMed ID: 19746844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trans-activation of herpes simplex virus type 1 immediate early genes is specifically inhibited by human recombinant interferons.
    De Stasio PR; Taylor MW
    Biochem Biophys Res Commun; 1989 Mar; 159(2):439-44. PubMed ID: 2539110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro studies of a co-carcinogenic effect of vaccinia and herpes group viruses.
    Mazurenko NP; Merekalova ZI; Pavlish OA; Bykovsky AF; Kurzman MJ; Mazurenko NN
    Neoplasma; 1981; 28(4):403-12. PubMed ID: 6270580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-proliferative effect of herpes simplex virus thymidine kinase gene system on human Tenon capsule fibroblasts in vitro].
    Wang JB; Ge J; Liu BQ; Huang B; Wei YT
    Zhonghua Yan Ke Za Zhi; 2006 Mar; 42(3):212-7. PubMed ID: 16643751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repression and activation of the genome of herpes simplex viruses in human cells.
    Wigdahl BL; Isom HC; Rapp F
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6522-6. PubMed ID: 6273875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A herpes simplex virus type 1 mutant deleted for gamma34.5 and LAT kills glioma cells in vitro and is inhibited for in vivo reactivation.
    Samoto K; Perng GC; Ehtesham M; Liu Y; Wechsler SL; Nesburn AB; Black KL; Yu JS
    Cancer Gene Ther; 2001 Apr; 8(4):269-77. PubMed ID: 11393279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct thymidine kinases encoded by cowpox virus and herpes simplex virus contribute significantly to the differential antiviral activity of nucleoside analogs.
    Prichard MN; Williams AD; Keith KA; Harden EA; Kern ER
    Antiviral Res; 2006 Aug; 71(1):1-6. PubMed ID: 16530858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.